A new nasal spray could soon offer Americans “fast-acting relief” from migraines and launch a new form of medicine onto the market, Pfizer announced on Thursday, touting promising results from late ...
SALT LAKE CITY--(BUSINESS WIRE)--Xlear has supplemented the numerous scientific studies it has already provided the Department of Justice and the Federal Trade Commission (FTC) in the government’s ...
The Food and Drug Administration on Friday approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option. The drug, Zavzpret, also known as ...
The #1 physician trusted cough and cold brand* introduces new product innovation just in time for another cold & flu season PARSIPPANY, N.J., Sept. 23, 2024 /PRNewswire/ -- If you're one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results